Novavax's Updated Protein-based COVID-19 Vaccine Now an Opti

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Nuvaxovid™...

Related Keywords

India , Germany , Ali Chartan , Johnc Jacobs , Erika Schultz , Drug Administration , Intj Environ Res Public Health , Serum Institute Of India Pvt , Vaccine Administration Errors , World Health Organization , Novavax Inc , European Union , Exchange Commission , Nasdaq , Centers For Disease , Council Of The European Union , Linkedin , Emergency Use Listing , Use Listing , Chief Executive Officer , Emergency Use Authorization , Coronavirus Disease , Fact Sheet , Disease Control , Vaccine Adverse Event Reporting System , Fax Number , Telephone Number , Adverse Events , Vaccine Administration , Serum Institute , Financial Condition , Annual Report , Quarterly Reports , Protein Based Vaccines , From Classical , Ecological Footprint , Estimating Greenhouse Gas Emissions , Intj Environ Res Public , Novavax , Nc ,